← Back to headlines
Eli Lilly Nears Acquisition of Cancer Biotech
Eli Lilly is reportedly close to finalizing a deal to acquire a cancer biotechnology company, signaling a strategic expansion in its oncology portfolio.
19 Apr, 21:20 — 19 Apr, 21:20
Sources
Showing 1 of 1 sources
